Report Detail
Global Adoptive Cellular Immunotherapy Market Growth (Status and Outlook) 2019-2024
- RnM3411957 |
- 13 May, 2019 |
- Global |
- 155 Pages |
- LPI(LP Information) |
- Other
Adoptive cellular immunity is the transfer of lymphocytes from the donor to the recipient to enhance its cellular immunity.
According to this study, over the next five years the Adoptive Cellular Immunotherapy market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Adoptive Cellular Immunotherapy business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Adoptive Cellular Immunotherapy market by product type, application, key companies and key regions.
This study considers the Adoptive Cellular Immunotherapy value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
TIL
LAK
TCR-T
CIK
NK
DC
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Hospital
Cancer Hospital
Centers for Disease Control and Prevention
Rehabilitation Center
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Amgen Inc
Autolus Therapeutics Plc
Beijing Immunochina Medical Science & Technology Co Ltd
Bellicum Pharmaceuticals Inc
Bristol-Myers Squibb Co
bluebird bio Inc
CARsgen Therapeutics Ltd
Celgene Corp
Cell Medica Ltd
Cellular Biomedicine Group Inc
Celularity Inc
Celyad SA
Daiichi Sankyo Co Ltd
Fosun Pharmaceutical AG
Gilead Sciences Inc
Guangzhou Anjie Biomedical Technology Co Ltd
Hangzhou Converd Co Ltd
Hebei Senlang Biotechnology Inc Ltd
HRAIN Biotechnology Co Ltd
Juno Therapeutics Inc
Kite Pharma Inc
Nanjing Legend Biotech Co Ltd
NantKwest Inc
Nkarta Inc
Novartis AG
Ono Pharmaceutical Co Ltd
Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
Sorrento Therapeutics Inc
Takara Bio Inc
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Adoptive Cellular Immunotherapy market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Adoptive Cellular Immunotherapy market by identifying its various subsegments.
Focuses on the key global Adoptive Cellular Immunotherapy players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Adoptive Cellular Immunotherapy with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Adoptive Cellular Immunotherapy submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Adoptive Cellular Immunotherapy Market Report (Status and Outlook)
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Adoptive Cellular Immunotherapy Market Size 2014-2024
- 2.1.2 Adoptive Cellular Immunotherapy Market Size CAGR by Region
- 2.2 Adoptive Cellular Immunotherapy Segment by Type
- 2.2.1 TIL
- 2.2.2 LAK
- 2.2.3 CAR-T
- 2.2.4 TCR-T
- 2.2.5 CIK
- 2.2.6 NK
- 2.2.7 DC
- 2.2.8 Other
- 2.3 Adoptive Cellular Immunotherapy Market Size by Type
- 2.3.1 Global Adoptive Cellular Immunotherapy Market Size Market Share by Type (2014-2019)
- 2.3.2 Global Adoptive Cellular Immunotherapy Market Size Growth Rate by Type (2014-2019)
- 2.4 Adoptive Cellular Immunotherapy Segment by Application
- 2.4.1 Hospital
- 2.4.2 Cancer Hospital
- 2.4.3 Centers for Disease Control and Prevention
- 2.4.4 Rehabilitation Center
- 2.4.5 Other
- 2.5 Adoptive Cellular Immunotherapy Market Size by Application
- 2.5.1 Global Adoptive Cellular Immunotherapy Market Size Market Share by Application (2014-2019)
- 2.5.2 Global Adoptive Cellular Immunotherapy Market Size Growth Rate by Application (2014-2019)
3 Global Adoptive Cellular Immunotherapy by Players
- 3.1 Global Adoptive Cellular Immunotherapy Market Size Market Share by Players
- 3.1.1 Global Adoptive Cellular Immunotherapy Market Size by Players (2017-2019)
- 3.1.2 Global Adoptive Cellular Immunotherapy Market Size Market Share by Players (2017-2019)
- 3.2 Global Adoptive Cellular Immunotherapy Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Adoptive Cellular Immunotherapy by Regions
- 4.1 Adoptive Cellular Immunotherapy Market Size by Regions
- 4.2 Americas Adoptive Cellular Immunotherapy Market Size Growth
- 4.3 APAC Adoptive Cellular Immunotherapy Market Size Growth
- 4.4 Europe Adoptive Cellular Immunotherapy Market Size Growth
- 4.5 Middle East & Africa Adoptive Cellular Immunotherapy Market Size Growth
5 Americas
- 5.1 Americas Adoptive Cellular Immunotherapy Market Size by Countries
- 5.2 Americas Adoptive Cellular Immunotherapy Market Size by Type
- 5.3 Americas Adoptive Cellular Immunotherapy Market Size by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Adoptive Cellular Immunotherapy Market Size by Countries
- 6.2 APAC Adoptive Cellular Immunotherapy Market Size by Type
- 6.3 APAC Adoptive Cellular Immunotherapy Market Size by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Adoptive Cellular Immunotherapy by Countries
- 7.2 Europe Adoptive Cellular Immunotherapy Market Size by Type
- 7.3 Europe Adoptive Cellular Immunotherapy Market Size by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Adoptive Cellular Immunotherapy by Countries
- 8.2 Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Type
- 8.3 Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global Adoptive Cellular Immunotherapy Market Forecast
- 10.1 Global Adoptive Cellular Immunotherapy Market Size Forecast (2019-2024)
- 10.2 Global Adoptive Cellular Immunotherapy Forecast by Regions
- 10.2.1 Global Adoptive Cellular Immunotherapy Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
- 10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
- 10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
- 10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
- 10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
- 10.7 Global Adoptive Cellular Immunotherapy Forecast by Type
- 10.8 Global Adoptive Cellular Immunotherapy Forecast by Application
11 Key Players Analysis
- 11.1 Amgen Inc
- 11.1.1 Company Details
- 11.1.2 Adoptive Cellular Immunotherapy Product Offered
- 11.1.3 Amgen Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2019)
- 11.1.4 Main Business Overview
- 11.1.5 Amgen Inc News
- 11.2 Autolus Therapeutics Plc
- 11.2.1 Company Details
- 11.2.2 Adoptive Cellular Immunotherapy Product Offered
- 11.2.3 Autolus Therapeutics Plc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2019)
- 11.2.4 Main Business Overview
- 11.2.5 Autolus Therapeutics Plc News
- 11.3 Beijing Immunochina Medical Science & Technology Co Ltd
- 11.3.1 Company Details
- 11.3.2 Adoptive Cellular Immunotherapy Product Offered
- 11.3.3 Beijing Immunochina Medical Science & Technology Co Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2019)
- 11.3.4 Main Business Overview
- 11.3.5 Beijing Immunochina Medical Science & Technology Co Ltd News
- 11.4 Bellicum Pharmaceuticals Inc
- 11.4.1 Company Details
- 11.4.2 Adoptive Cellular Immunotherapy Product Offered
- 11.4.3 Bellicum Pharmaceuticals Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2019)
- 11.4.4 Main Business Overview
- 11.4.5 Bellicum Pharmaceuticals Inc News
- 11.5 Bristol-Myers Squibb Co
- 11.5.1 Company Details
- 11.5.2 Adoptive Cellular Immunotherapy Product Offered
- 11.5.3 Bristol-Myers Squibb Co Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2019)
- 11.5.4 Main Business Overview
- 11.5.5 Bristol-Myers Squibb Co News
- 11.6 bluebird bio Inc
- 11.6.1 Company Details
- 11.6.2 Adoptive Cellular Immunotherapy Product Offered
- 11.6.3 bluebird bio Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2019)
- 11.6.4 Main Business Overview
- 11.6.5 bluebird bio Inc News
- 11.7 CARsgen Therapeutics Ltd
- 11.7.1 Company Details
- 11.7.2 Adoptive Cellular Immunotherapy Product Offered
- 11.7.3 CARsgen Therapeutics Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2019)
- 11.7.4 Main Business Overview
- 11.7.5 CARsgen Therapeutics Ltd News
- 11.8 Celgene Corp
- 11.8.1 Company Details
- 11.8.2 Adoptive Cellular Immunotherapy Product Offered
- 11.8.3 Celgene Corp Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2019)
- 11.8.4 Main Business Overview
- 11.8.5 Celgene Corp News
- 11.9 Cell Medica Ltd
- 11.9.1 Company Details
- 11.9.2 Adoptive Cellular Immunotherapy Product Offered
- 11.9.3 Cell Medica Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2019)
- 11.9.4 Main Business Overview
- 11.9.5 Cell Medica Ltd News
- 11.10 Cellular Biomedicine Group Inc
- 11.10.1 Company Details
- 11.10.2 Adoptive Cellular Immunotherapy Product Offered
- 11.10.3 Cellular Biomedicine Group Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2019)
- 11.10.4 Main Business Overview
- 11.10.5 Cellular Biomedicine Group Inc News
- 11.11 Celularity Inc
- 11.12 Celyad SA
- 11.13 Daiichi Sankyo Co Ltd
- 11.14 Fosun Pharmaceutical AG
- 11.15 Gilead Sciences Inc
- 11.16 Guangzhou Anjie Biomedical Technology Co Ltd
- 11.17 Hangzhou Converd Co Ltd
- 11.18 Hebei Senlang Biotechnology Inc Ltd
- 11.19 HRAIN Biotechnology Co Ltd
- 11.20 Juno Therapeutics Inc
- 11.21 Kite Pharma Inc
- 11.22 Nanjing Legend Biotech Co Ltd
- 11.23 NantKwest Inc
- 11.24 Nkarta Inc
- 11.25 Novartis AG
- 11.26 Ono Pharmaceutical Co Ltd
- 11.27 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
- 11.28 Sorrento Therapeutics Inc
- 11.29 Takara Bio Inc
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Adoptive Cellular Immunotherapy . Industry analysis & Market Report on Adoptive Cellular Immunotherapy is a syndicated market report, published as Global Adoptive Cellular Immunotherapy Market Growth (Status and Outlook) 2019-2024. It is complete Research Study and Industry Analysis of Adoptive Cellular Immunotherapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
